A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.
MedPage Today on MSN
Rapid-Acting Drug for Major Heart Attacks Hits Main Goal in Trial
NEW ORLEANS -- Patients experiencing major heart attacks had a lower risk of serious complications if they received a single ...
Patients with radiologically staged T3-4, N0-2, M0 colon cancer were randomly allocated (2:1) to 6 weeks oxaliplatin-fluoropyrimidine preoperatively plus 18 postoperatively (NAC group) or 24 weeks ...
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...
Publication of Interim Results and Presentation at Recent Industry Event Demonstrate Clinical Benefit Associated with Use of ...
University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder ...
Group announced the publication of interim results from its CAMPAIGN trial, a randomized controlled trial designed to evaluate the ...
Pegozafermin is a long-acting glycopegylated (pegylated with the use of site-specific glycosyltransferases) fibroblast growth factor 21 (FGF21) analogue in development for the treatment of ...
Penumbra, Inc. (NYSE: PEN) announced additional results of the ground-breaking STORM-PE randomized controlled trial (RCT), ...
Findings from observational studies suggest that dietary patterns may offer protective benefits against cognitive decline, but data from clinical trials are limited. The Mediterranean–DASH ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback